| Management target | Revenue 100.0% FY27 |
|---|
| Revenue growth | 22% YoY growth driven by Rajasthan and retail expansion. |
|---|---|
| Margins | EBITDA margin fell to 25% due to upfront project costs. |
| Demand visibility | Strong visibility via long-term PPP contracts and retail network growth. |
| Management confidence | Balanced confidence despite temporary margin pressure from new projects. |
Growth
Revenue grew 22% YoY; like-for-like projects grew 12%. Retail revenue surged 64%.
Outlook
Projected Rajasthan revenue of ₹150-170Cr; retail expected to reach 10-15% of total mix.
Risks
Margin compression from upfront Rajasthan costs; significant receivables delays in Karnataka and Himachal Pradesh.
Last quarter's promises, checked
Delivered
- Guided 200+ CT/MRI centers → delivered 190+ with 17 in pipeline (= BEAT)
- Guided 54 NABL labs → delivered 54 NABL labs (= BEAT)
- Guided virtually 0 bad debt → delivered 0 bad debt despite delays (= BEAT)
Partly delivered
- Guided Rajasthan revenue ₹250-300Cr → delivered guidance cut to ₹150-170Cr (= PARTIAL)
- Guided retail contribution double-digits → delivered 8% (= PARTIAL)
Missed
- Guided EBITDA margin 29-30% → delivered 25% (= MISS)
- Guided receivables to 100 days → delivered 139 days (= MISS)
Earnings Call Transcript filed with BSE, NSE: KRSNAA. Summary written with AI assistance from the document.
Krsnaa Diagnostics Ltd: key numbers
- Share price
- ₹550.00
- Market cap
- ₹1,784 Cr
- Revenue (annual)
- ₹772.8 Cr
- Net profit (annual)
- ₹101.4 Cr
- P/E (TTM)
- 18.3×Sector 53.1×
- Promoter holding
- 27.11%+0.00% QoQ
- FII holding
- 4.28%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Krsnaa Diagnostics Ltd
All →Krsnaa Diagnostics Annual General Meeting
Krsnaa Diagnostics Ltd reported the successful passing of a special resolution via postal ballot approving the issuance of up to 16,21,000 convertible warrants to promoters.
Krsnaa Diagnostics Bags New Order from Department of Health & Family Welfare, Government of Punjab
Krsnaa Diagnostics executed a 15-year concession agreement with the Punjab Government to develop and operate PET-CT diagnostic facilities at four government hospitals.
- From
- Department of Health & Family Welfare, Government of Punjab
- Execution
- 15 years
- diagnostic facilities
- 4.0 hospitals
Krsnaa Diagnostics Legal & Regulatory
Krsnaa Diagnostics received tax appellate orders for AY 2017-24 with aggregate disputed demands of ₹62.69 Crore. The company plans to file further appeals.
- Value
- ₹62.69 Cr
Krsnaa Diagnostics Other Announcement
Krsnaa Diagnostics has filed its Business Responsibility and Sustainability Report for the financial year 2025-26 as required by regulatory listing obligations.
Krsnaa Diagnostics Annual General Meeting
Krsnaa Diagnostics Limited has submitted the notice of its 16th Annual General Meeting, scheduled for September 28, 2026, along with the Annual Report for 2025-26.
Krsnaa Diagnostics Annual General Meeting
Krsnaa Diagnostics issued a corrigendum to its Postal Ballot notice, providing additional disclosures regarding the proposed preferential issue of share warrants to promoters.